Home » Oxford Nanopore

Oxford Nanopore

Oxford Nanopore Technologies was founded in 2005 to develop an electronic, single molecule sensing system based on nanopore science. The company now has more than 250 employees from multiple disciplines including nanopore science, molecular biology and applications, informatics, engineering, electronics, manufacturing and commercialization. Oxford Nanopore's instruments — MinIon, PromethIon, and GridIon are adaptable for the analysis of DNA, RNA, proteins, small molecules and other types of molecule.

Oxford Nanopore Facts

 

CEO: Gordon Sanghera

Website: www.nanoporetech.com

Ticker symbol: Privately held

Headquarters: Oxford, UK

Number of employees: 250+

Sep 13, 2018

Vertebrate Genomes Project Releases First Assemblies; Describes Challenges, Plans

Premium

The VGP released its first 15 high-quality reference genome assemblies today, which are part of the project's first phase to sequence 260 vertebrate genomes.

Jul 30, 2018

Predicted to Grow

The South China Morning Post reports that DNA testing kit makers are investing in China.

Jul 09, 2018

Grandomics Raises Nearly RMB 100M in Series B Financing

The Beijing-based firm said it will use the funding for research and development, to obtain additional intellectual property, and to pursue its strategic goals.

Jun 19, 2018

Dual Listings Sought

Oxford Nanopore Technologies is looking into dual listings in London and Hong Kong, according to the South China Morning Post.

Jun 14, 2018

Oxford Nanopore's Revenues Triple in 2017

The company had £13.8 million ($18.4 million) in revenues and a net loss of £56.6 million in 2017.

Jun 14, 2018

DNA Scaffolds Could Enable Construction of Custom Nanopores for Protein Sequencing

Premium

University of Oxford researchers used DNA scaffolds to build custom peptide nanopores that they said could make nanopore-based protein analysis more feasible.

May 31, 2018

Oxford Nanopore Outlines Droplet-Based Sequencing Technology, Planned Updates

Premium

CTO Clive Brown provided an overview of the new approach during a presentation at the firm's user meeting last week.

May 18, 2018

New Products Posted to GenomeWeb: Oxford Nanopore, Invivoscribe, Precipio, More

May 08, 2018

PacBio, Oxford Nanopore Settle Patent Dispute in Europe

Under the terms of the agreement, Oxford Nanopore Technologies will not sell its 2D sequencing products in the UK and in Germany for five years.

May 01, 2018

New Tools Highlight Long-Read Sequencing Platforms' Ability to Call Structural Variants

Premium

Researchers validated 95 percent of structural variants called by PacBio sequencing versus 43 percent with Oxford Nanopore, while Illumina missed thousands.

Pages

The Scan

Closely Intertwined

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Little From Here and There

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

This Week in Science

In Science this week: in vitro generation of human reproductive cells, and more.

All the Arms for Hugging

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2018 GenomeWeb LLC.  All Rights Reserved.